Neuroscience Working Table
We seek to advance targeted legislative policies to solve problems related to the development of treatments for Neuroscience diseases, including through the establishment of a Neuroscience Center of Excellence (NCOE) at the Food and Drug Administration (FDA).
Who We Are
The Neuroscience Working Table consists of stakeholders, including patient groups, manufacturers, providers, and researchers, with a common interest in advancing legislative reforms to foster development in neuroscience.
The Neuroscience Working Table brings together technical expertise, real world experience, regulatory knowledge, public policy understanding, and government affairs expertise to develop and drive a consensus proposal to achieve this goal.
Understanding the Need for a Neuroscience Center of Excellence at the FDA